by Pete Celano | Oct 19, 2026 | Blog
Fatty liver disease can follow very different paths—and someone’s weight or diabetes status may not reveal how serious their liver risk is. That is the main message of this study from Mayo Clinic and Virginia Tech. Researchers analyzed medical records and genetic...
by Pete Celano | Oct 10, 2026 | Blog, Press
Liver disease access in the USA? Months-out, in person. LiverRight makes it same-week, telemedicine. Refer to our clinic in all 50 states, and we’ll deliver on liver for YOUR patients. We take most insurances and offer cash-pay options for adults across all...
by Pete Celano | Oct 7, 2026 | Blog
Here’s an important LiverRight patient-education topic, because the intuitive consumer belief—”Tylenol affects the liver, therefore Advil must be safer for liver patients”—misses the much more important NSAID risk in advanced liver disease.The...
by Pete Celano | Oct 1, 2026 | Blog, Press
by Pete Celano | Sep 17, 2026 | Blog
Consider “Study Finds Why Young Adults May Develop Early Fatty Liver Disease (Genetics and type 2 diabetes can help identify individuals at risk for advanced liver disease before age 50, leading to earlier liver cancer screening and treatment)” from...